Background-Primary tracheal tumours
are rare, so few physicians have extensive experience of their management. No direct comparisons have been made of surgical and radiotherapy treatment. Methods-A postal survey of cases presenting in the last 10 years in the United Kingdom was conducted. Results were expressed as cumulative survival and survival curves were compared by the log rank test. Results-Three hundred and twenty one patients were recruited. Overall five year survival rates were 25% for squamous cell carcinomas, and 80% for adenoid cystic carcinoma; 62% received radiotherapy but only 10% underwent surgery. Small cell carcinoma was more common than expected with an incidence of 6%. In patients with squamous carcinoma improved survival was seen in those with tumour in the upper trachea. High dose radiotherapy was more effective than low dose only in tumours of the upper trachea and in squamous carcinoma. In adenoid cystic carcinoma no significant difference in survival rate was seen between treatment with radiotherapy and surgery. No histological diagnosis was made in 44 patients, the most common reason being fear over the safety of fibreoptic bronchoscopy; however, this group had a cumulative survival at five years of 46%. Conclusions-Survival may be somewhat better in cases with tracheal tumours than in those with bronchial tumours.
Small cell carcinoma is less rare than was previously thought. Upper tracheal tumours may merit more aggressive therapy. It (fig 2) . High dose radiotherapy (6000 cGy) was more effective with a 75% five year survival than lower dose treatment (4000-4999 cGy) with a 20% survival for carcinoma of the upper trachea (p < 0 05). In the lower trachea, however, no relationship between dose and survival could be shown.
Few replies were received on patients treated with surgery. The majority of these had adenoid cystic carcinoma and no differ- in the study by Grillo and Matheson7, in which 11 of 31 patients (35%) were alive at five year follow up.
No study has yet satisfactorily shown whether surgery, radiotherapy, or the combination is the best treatment. The present study shows some interesting new features, but has also failed to effectively compare radiotherapy with surgery because of the very heavy bias, in the cases reported to us, in favour of radiotherapy.
As a retrospective study our data clearly have important limitations. The sites of tumours may not always have been accurately documented, the histological diagnosis has not been independently checked, nor have radiographs or computed tomographic scans been reviewed. The cases reported were roughly equally distributed between centres with some experience of these tumours and others who had only seen occasional cases. We have only been able to report those cases which respondents could recall, and have no way of confirming how many other causes they may have forgotten.
We have therefore attempted to estimate the total number of cases that should have been reported with a perfect study. From a view of mortality statistics (Office of Population Census) over the study period we can estimate the likely total cohort of patients which our study has sampled because most of the patients reported to us had already died. Although we asked for any cases recalled in the last 20 years, most were diagnosed in the preceding 10 years. Over this period the average annual mortality reported for Scotland was about 25 deaths per year, and for England and Wales about 66 per year. For the UK the total average annual mortality would therefore be 91, and the total deaths in 10 years would be 910. Having located 321 patients we have therefore, probably reported about one third of the cases that actually occurred. Since we only had 25 cases reported from Scotland, we therefore found 296 cases from an estimated 660 deaths in 10 years from England and Wales, which gives a rather better detection rate of about 45%. This estimation, of course, ignores the probability that some deaths from tracheal tumours are misdiagnosed and labelled as being due to asthma or chronic bronchitis and emphysema. To independently verify all the information received would be an enormous task and some data such as radiographs may have been destroyed. Nevertheless, we believe that the size of our study should at least partly compensate for these obvious limitations.
The 321 cases described make this the largest series of primary tracheal tumours reported in the world literature. Our five year survival rate of 25% for squamous carcinomas and 80% for adenoid cystic carcinomas are in keeping with previous experience ( the trachea compares favourably with an overall figure of about 5% for all stages of non-small cell carcinoma of the bronchus.14 Greater efforts to improve treatment would therefore seem justifiable. Unlike bronchial carcinoma which occurs predominantly in men, sex incidence appears to be equal in tracheal tumours; evidence suggesting an association with smoking was found in squamous and small cell carcinomas. Small cell carcinoma of the trachea was previously considered very rare but we found an incidence of about 6% (a similar incidence to that reported by Roston and Morgan'2). The survival rates in the few cases we had were perhaps better than one might expect in comparison with bronchial tumours, since most were treated predominantly with radiotherapy and did not have modem chemotherapy regimes.'5 Since 62% of patients had radiotherapy and few had no treatment, we have no control group to assess the benefit of radiotherapy. In adenoid cystic carcinoma the longer survival time would make this even more difficult to study. However, in our largest group-the squamous cell carcinomas-we tried to look for a dosage effect as another way of assessing whether radiotherapy improved survival. Three dose ranges were compared and radical treatment with 6000 cGy was found to improve survival, but this benefit was only seen in patients with upper tracheal tumours. We have also shown a general improvement in the rate of survival for patients with upper tracheal tumours which has not been reported before. These appear to be independent variables, and suggest that aggressive treatment may be particularly indicated in upper tracheal tumours. These conclusions are, of course, subject to the possibility that some of the lower tracheal tumours were, in fact, extensions of carinal and bronchial tumours and would therefore have a particularly poor prognosis. Even if this is the case, it would still indicate a more aggressive approach to lesions in the upper trachea.
The small number of surgical cases cannot simply be due to the low response rate from surgeons, since any patients missed this way should have been picked up from the physicians who would see most cases first. Most of the surgical cases had adenoid cystic carcinoma or one of the rarer tumour types. This apparent low rate for surgery, particularly in squamous cell carcinoma, contrasts with North America where surgery is apparently more popular.7" We were only able to compare surgery and radiotherapy in the adenoid cystic carcinomas; no significant difference was found and the long natural survival time renders comparison difficult. Only six cases of squamous carcinoma underwent surgery with a small trend towards improved survival; however, most had upper tracheal tumours in which we have also shown improved survival for radiotherapy.
We were unable to assess the value of newer endoscopic techniques such as laser resection because of the small numbers treated, the range of histological types, and the wide variety of other treatments these patients received. The group with no histological diagnosis (14% of cases) had a relatively good five year survival of 46%. A number of cases of adenoid cystic and adenocarcinomas and rarer benign tumours may be included in this mixed group. Common reasons for failure to obtain histology were apparently fear of taking a biopsy sample from potentially vascular tumours and poor clinical condition, particularly with stridor. Since some of these cases did relatively well, even with extensive tumours, an accurate histological diagnosis is important as some patients may benefit from more aggressive treatment. We only saw one incidence of failure to make a diagnosis at rigid bronchoscopy, so if fibreoptic bronchoscopy is considered unsafe or fails to give a diagnosis we would most strongly urge referral to a colleague skilled in rigid bronchoscopy.
This study highlights the need for referral to specialised centres so that treatment can be best coordinated to patients' needs and better prospective data obtained. Only a randomised prospective comparative trial of surgery and radiotherapy can show which is best and the rarity of these tumours makes recruitment to such a study very difficult. Nevertheless, it appears that prognosis for these tumours could be improved and, in view of the miserable deaths which otherwise occur, we believe such studies should be pursued. With the collaboration of the British Thoracic Society Research Committee we are now establishing a study to monitor prospectively treatment of primary tracheal tumours on a national scale by interested surgeons and radiotherapists which should overcome the limitations of this retrospective study.
